1. Home
  2. FT vs DTIL Comparison

FT vs DTIL Comparison

Compare FT & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Universal Trust

FT

Franklin Universal Trust

SELL

Current Price

$7.09

Market Cap

178.7M

Sector

Finance

ML Signal

SELL

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

SELL

Current Price

$6.00

Market Cap

197.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FT
DTIL
Founded
1988
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.7M
197.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FT
DTIL
Price
$7.09
$6.00
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $29.40
AVG Volume (30 Days)
60.1K
★ 253.5K
Earning Date
01-01-0001
11-02-2026
Dividend Yield
★ 7.85%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$3.53
52 Week High
$8.35
$9.62

Technical Indicators

Market Signals
Indicator
FT
DTIL
Relative Strength Index (RSI) 36.55 36.25
Support Level $6.95 $5.35
Resistance Level $8.32 $7.55
Average True Range (ATR) 0.08 0.33
MACD 0.03 0.03
Stochastic Oscillator 58.00 7.00

Price Performance

Historical Comparison
FT
DTIL

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: